Aviation Medication Transparency Act of 2026

Section 2(b) requires the FAA Administrator to publish and maintain a publicly available list of medications that have been approved for medical certification or clearance. This is positive because it gives pilots and air traffic controllers clear information on what medications they can safely take.

Section 2(c)(3) requires the medication list to be made available in a user-friendly and accessible manner on MedXPress when individuals first seek medical certification. This helps trainees and workers easily find the health guidance they need without hunting through complicated documents.

Section 2(c)(6) requires the inclusion of contact information for doctors and medical providers to ask the FAA questions related to the medication list. This benefits individuals by helping their personal physicians communicate directly with the aviation authorities about safe treatment options.

Section 2(e) states that publishing the medication list does not assign liability to the Administrator if an individual relies on the list and experiences an adverse medical reaction. This means workers bear the personal risk even if they followed the published FAA list.

Section 2(e)(2) clarifies that the Administrator is not liable if a person causes harm or injury to persons or property after using a medication from the list. Individuals could still face severe personal or legal consequences for accidents even when using approved medications.

Section 2(e)(3) notes that the Administrator is not liable if a person is deemed ineligible for a medical certification or clearance after using a listed medication. Workers might still lose their medical clearance or livelihood despite attempting to follow the published guidance.